Picking Gold From A Gold Mine

Anglo Swiss Resources Inc.
(TSX-V: ASW) (OTCBB: ASWRF) (BERLIN: AMO)
Basic Shares 130.2 million
Fully Diluted 150 million

-------------------------------------------------------------

Over the past two years Anglo Swiss has been busy rehabilitating its primary mine adit called the 257 level at its Kenville property just outside of Nelson BC. This mine consists of a number of kilometers of new track laid into the gold and mineral filled mountain. Now that the mine has been brought back to commercial standards from its fifty plus year slumber the company has been intent on exploiting existing and new gold vein structures.

Aiming a drill bit from ground level into a vein structure that pinches and swells 200 metres below is not an easy task. This is one of the challenges of exploration drilling. Anglo now plans to do its drilling from underground in the mine adit where it can see the gold veins intersect through the tunnels.

To ensure that Anglo puts the drill into the most opportune places, the company has been taking wall chip samples inside the tunnels with gold content reaching as high as 210.5 grams per tonne or 7.43 ounces.

There is a massive amount of historical data being reviewed on the underground portion of Kenville including underground mapping, old drill hole logs and reports. The goal of the company is now to use this historical information along with new exploration to put together a technical report (NI 43-101) that is a compliant gold mineral resource estimate pinning a value on this portion of Kenville.

Drilling is planned to start in early May. The company plans to drill 12 thousand metres underground plus some ground level in-fill drilling to identify the un-mined resource below the 257 level.

See full news release here..........

NXT Weathered 2008 and a Positive Outlook for 2009

NXT Energy Solutions Inc.
TSX-V : SFD / OTCBB : NSFDF / Frankfurt : EFW
Basic Shares - 30.6 Million
Fully Diluted - 42.7 Million
--------------------------------------------------------------

NXT Energy Solutions released its 2008 year end financials and Management’s Discussion & Analysis (MD&A) last week, both of which are available on SEDAR. The MD&A outlines a busy year for NXT in 2008, in which many of its milestones were accomplished. It also provides some insight into what’s in store for shareholders for 2009. Highlights included:

· “…we can build on the commercial and technical successes realized from previous client surveys. These surveys provide invaluable case studies; client endorsements and industry recognition that are required to broaden the market adoption of our services.”

· “Furthermore in 2008, to develop a market focus for our business plan, we began assessing various international market opportunities for our services. These initiatives include attending industry conferences, conducting in-house evaluations of potential international markets, consulting with international agents and drawing upon the vast experience of our Board of Directors and Geosciences Advisory Board.”

· “We recently announced the appointment of Mr. Murray Christie as our Chief Operating Officer. Mr. Christie’s career includes over 15 years of geological modeling and geophysical survey experience providing leading edge technology solutions to international and domestic oil and gas clients.”

· “Particularly, our recent attendance at industry conferences has significantly advanced our business plan development. They provided market intelligence, access to key decision makers and advisors and provided excellent forums to introduce and stimulate dialogue on our SFD technology.”

· “Our 2009 objective is to focus on revenue growth through the implementation of new marketing, sales and technical strategies that showcase our past achievements.”

· “With significant cash reserves we have the financial resources to execute our business plan, expand the management team and pursue targeted international opportunities evident in this challenging market.”

And you read that right, NXT used its MD&A to announce a signed letter of intent to provide its SFD services in Columbia.

“We have recently executed a letter of intent to provide U.S. $2.3 million of SFD survey services in Colombia for a Colombian subsidiary of a Canadian oil and gas company. This letter of intent is subject to the execution of the definitive agreements and receiving NXT’s Board approval. In addition, we have engaged in discussions regarding surveys in other locations of the world.”

To view NXT’s 2008 MD&A click here

To view NXT’s year end financials click here

Click here for investor relations professional disclaimer

Research Capital Pens Another Upbeat AMA Report

AeroMechanical Services Ltd. (TSX:V-AMA)
Basic Shares: 82.5 million
Fully Diluted:88 million



*********************************************

Some clouds hanging over AeroMechanical were removed lately, Research Capital's aviation analyst Jacque Kavafian noted in a recent research report update.

And spring temperatures rose after AMA filed a relatively upbeat 2008 annual report and reported a new sales contract all in the same short period, he added.
While Mr. Kavafian lowered his previous estimates for installation of AMA blueboxes and of new orders going forward, he maintained his share target price of $0.65.

The clouds he cited disappeared after AMA reached a settlement with its former President Darryl Jacobs, who sued AMA for wrongful dismissal, and after Star Navigation tucked its corporate tail between its legs by abandoning its patent infringement suit against AMA. (It is interesting to note that following Star's retreat, AMA filed a motion to have Star repay AMA nearly US$750,000 in legal fees.)
"The negatives weighing on the stock are largely gone and full efforts are being made to make the company cash-flow positive in F2010 ..." Mr. Kavafian wrote.

In the annual report, the analyst noted that AMA had $800 thousand in its cash coffers and $2.8 million in receivables and inventory - inventory that gets converted to cash as soon as it is used.
That, its backlog of sales orders and the fact it has almost no debt inspired Mr. Kavafian to conclude that AMA, "will be able to meet its near-term working capital requirements..."
"In addition, (AMA's) agreement with Sierra Nevada Corporation (SNC) to manufacture and market AMA's (bluebox technology) under license to the U.S. military market should also help through license fees and royalties and reduced research and development burden as some of the responsibility will shift to SNC," Mr. Kavafian added.
He noted AMA had 184 of its blueboxes installed in aircraft around the world at the end of 2008. But he reduced that number by 33 to account for the three airline customers who bit bullets in these tough markets and went out of business.

That left AMA with 227 aircraft under contract and 151 blueboxes actually installed on Dec. 31st, 2008.
"We will be watching the flow of orders and if the pace picks up with the backlog growing to over 300 units, we may have to increase our valuation (beyond $0.65 cents per share,)" Mr. Kavafian wrote.

In better economic times, Mr. Kavafian estimated that AMA would install 135 blueboxes in F2009 and 377 units in F2010. But given the tough economic times, he lowered his previous estimates to 75 units in F2009 and 88 units in F2010.
To read the full report, please click here.

LMS Software Draws the Attention of ABC in Flint, Michigan

LMS Medical Systems (LMZ - TSX)
Shares outstanding: 25.8m
Fully Diluted: 30.7 million

-------------------------------------------------------------

LMS’ CALM Shoulder Screen™ technology was the focus of a two minute health feature on ABC12 - WJRT-TV Mid Michigan. Posted to the affiliate’s website on Friday, April 24th, it gives viewers a very good overview of how Shoulder Screen™ works and risks associated with Shoulder Dystocia – the potentially debilitating birth injury that LMS Shoulder Screen is designed to prevent.



Quick Facts on Shoulder Dystocia

"ACOG data shows that shoulder dystocia for 17% of all obstetrical claims"- Health Systems Risk Management Advisor, July 2005

• Shoulder dystocia with neonatal injury occurs in about 0.4 to 3 vaginal births per 1000;
  
  
• Short mothers, maternal obesity and large babies are the principal risk factors;
  
  
• Rates of maternal obesity (a risk factor) are increasing;
  
  
• Medical liability payouts for a baby with subsequent disability average around $500,000.
  

To view the two minute spot click here

To read the article on WJRT-TV website click here

* LMS Medical Systems’ contact information is provided at the bottom of the website article. *

Med BioGene Announces Private Placement and Financial Commitment from Berkeley Capital

MED BIOGENE INC. (MBI:TSX-V)
Basic shares: 41 million
Fully diluted: 63 million


------------------------------------------------------------------------

In a news release disseminated on Wednesday, MBI announced a non-brokered private placement of a minimum of $1.3 million and a maximum of $1.6 million of units.

Each unit will be issued at a price of $0.08 and will consist of one common share and one-half of one common share purchase warrant. Each whole common share purchase warrant will entitle the holder to purchase one common share at a price of $0.10 for a period of 24 months.

It was also announced that Berkeley Capital Corp. II, a capital pool company listed on the TSX Venture Exchange (TSXV: BIZ.P), will participate in the private placement as the lead order. Under the agreement, Berkeley will invest all of its available cash reserves and subscribe to approximately $650,000 of units.

Med BioGene will use the proceeds of the private placement for the development and commercialization of LungExpress Dx(TM) and for general corporate purposes.

In connection with the Private Placement, Med BioGene will appoint Kevin K. Rooney, a current director of Berkeley, as a director of Med BioGene.

Here’s some background information on Mr. Rooney.

Mr. Rooney is a co-founding partner of Hayden Bergman Rooney, Professional Corporation, a leading corporate, securities and mergers and acquisitions boutique law firm in San Francisco, California, that represents clients in the United States and Canada. Mr. Rooney focuses on mergers and acquisitions and he heads the firm’s public company practice. Prior to joining Hayden Bergman Rooney in June 2005, Mr. Rooney was a corporate and securities associate at Davies Ward Phillips & Vineberg LLP in Toronto, a leading Canadian corporate transactions law firm, from October 2004 to May 2005, and Wilson Sonsini Goodrich & Rosati, Professional Corporation in Palo Alto, California, the world’s leading firm representing technology and growth companies, from July 2000 to September 2004. Mr. Rooney’s experience at such firms involved representing a number of public and private companies in mergers and acquisitions, corporate finance transactions and corporate governance and reporting. Prior to beginning his law practice, Mr. Rooney was an Engineering Specialist (Finance) at Unitel Communications Inc. in Toronto (now Allstream) from June 1994 to August 1996. Mr. Rooney is a director at Berkeley Capital Corp. II (TSX-V:BIZ.P) and a general partner of Bay Bridge Partners II, a California private investment partnership.

Mr. Rooney received a B.A.Sc. (Honours Co-op) in Mechanical Engineering (Management Science Option) from the University of Waterloo in 1994 and a LL.B. from Dalhousie University Law School in 1999. Mr. Rooney is an Adjunct Professor at the University of San Francisco School of Law teaching Corporate Transactions and an Adjunct Professor at University of California Berkeley HAAS School of Business co-teaching Business Law (MBA). He is a member of the TSX Venture Exchange Toronto Local Advisory Committee and the Law Society of Upper Canada and The State Bar of California.

The board of directors of Berkeley has unanimously approved Berkeley’s investment in MBI.

As part of the due diligence process, Berkeley’s board of directors retained Bloom Burton & Co. of Toronto, a leading boutique life science investment bank and advisory services firm, to opine on MBI’s technology, business and commercialization strategy. Bloom Burton & Co.’s principals are former Dundee Securities healthcare specialists, Jolyon Burton and Brian Bloom.

Closing of the Berkeley investment is subject to Berkeley shareholder approval and MBI raising in aggregate a minimum of $1.3 million in the private placement (including the funds to be invested by Berkeley).

If you are interested in participating in the private placement, please contact Peter Weichler, Managing Director of The Howard Group at 403.221.0912.

To read the full release, please click here.

NXT to Provide Update to Investors via Webcast/Conference Call

NXT Energy Solutions Inc.
TSX-V : SFD / OTCBB : NSFDF / Frankfurt : EFW
Basic Shares - 30.6 Million
Fully Diluted - 42.7 Million


--------------------------------------------------

In a news release distributed late yesterday, NXT invited shareholders to participate in a conference call at 4:30pm EST/2:30pm MST on Wednesday, April 29, 2009. The purpose of the call will be to discuss NXT’s 2008 financial results and 2009 operations. Shareholders will also be introduced to Murray Christie, COO; a recent strong addition to the management team.

To access the conference call please phone:

Direct: (913) 312-1491

Toll Free: (888) 218-8176

Ask the attendant for the "NXT Conference Call"

To view NXT’s presentation via webcast in sync with the conference call, please go to the NXT’s home page (http://www.nxtenergy.com/) and click the “NXT Conference Call” link. The link will be made available on the day of the call.

To read the full release, please click here.

Click here for investor relations professional disclaimer

The Great Wall Ends Here

Asia Now (TSX-V: NOW)
Basic Shares: 65.5 million
Fully Diluted: 68.3 million

-------------------------------------------------

Asia Now has decided to drop one of its key three properties in order to ensure the other two get the company's full attention.

The Great Wall project in the north east province of Hebei showed strong potential early in exploration but has since taken a back seat to the two more promising properties in the Yunnan province, Beiya and Habo.

The company has done what it needed to and will write off its stake and expenses relating to exploration of the Great Wall project totaling just under $700,000 in 2008.

Asia Now will continue exploration on Beiya and Habo where management is convinced that success will be found with the drill bit in the known mineralized zones here. The Beiya project surrounds the largest producing open pit gold mine in Yunnan.

See full news release here.............

It's The Recurring Revenue, Stupid

AeroMechanical Services Ltd. (TSX:V-AMA)

Basic Shares: 82.5 million

Fully Diluted:88 million

***********************

Please click on the individual graphs below to enlarge

At one point during a particularly bad period in Bill Clinton's run for President, the campaign staff were in a state of absolute confusion about the myriad choices they had to shape his run for the White House.
Clinton's campaign manager cut to the chase by shouting: "It's the economy, stupid!"

That sharp focus turned the floundering campaign around.

Investors should also cast the same steely-eyed focus on AeroMechanical's 2008 annual report and say to themselves: "It's the recurring revenue, stupid!"

It moved from $607 thousand in 2006 for AMA's bluebox technology to $902 thousand in 2007. But by the end of 2008 it chimed in at $2.36 million, a nearly three-fold increase. Please note the bar chart that illustrates the growth in quarterly recurring revenue with Q4/2008 breaking through $1 million!

Cash revenues also climbed impressively, moving from $1.39 million in 2006, to $2.63 million in 2007 and closing 2008 at $5.25 million. As a side note, when you examine the financial statements you'll see reported revenues for 2008 of $3.176 million. The difference between this number and the actual cash through the door is related to accounting standards that mandate the revenues must be attributed over the term of a contract.

Mind you, costs in a very tough selling year when the airline industry faced the double economic blows of soaring fuel prices and a tanking general economy - were also up. So much so that the net loss for the year ending Dec. 31st was $8.52 million, compared to $6.86 million in 2007.

But AMA made great strides by reeling in costs. For example, it cost $1.63 for every $1 in revenue in 2008, compared to a much higher cost of $2.60 for every $1 in revenue in 2007.

Because of nimble footwork like that - coupled with the dramatic rise in cash and recurring revenues - AMA executives remain confident they will prosper from the storm and will likely not have to seek a new financing.
One of the major reasons for that confidence, is the addition of the fuel-saving program to AMA's already impressive capabilities of its technology.
The fuel saving program can chop 3-6% of an airline's fuel bill, a bill that combined with labour costs can account for over 25% of an airline's annual operating costs.
Because industry margins are so tight, the ability to cut up to 6% off costs has airline executives doing a double take.
As AMA President Richard Hayden pointed out in his letter to shareholders, the payback of having the fuel-saving program added to AMA's bluebox technology gives airlines an "immediate and very material" reason for signing on with AMA.
While on the topic of new customers, Mr. Hayden pointed out the recent partnership with the billion-dollar private U.S. aeronautics firm, Sierra Nevada Corporation, gives AMA the "corporate bulk" that sets AMA apart from all others in the field. This association gives AMA the clout to deal with OEMs and major airlines that a small company wouldn't normally enjoy.
And there was another intriguing aspect to the Management Discussion and Analysis report that accompanied the annual report.
That gem is that AMA is also working with a "major supplier" to provide airlines with the ability to get real-time approvals for credit card purchases for everything from movies to meals, drinks and even duty-free items most airlines now offer on board.
To read the entire report please click here.

TSX Gives LMS Medical another 60 Days

LMS Medical Systems (LMZ - TSX)
Shares outstanding: 25.8m
Fully Diluted: 30.7 million

-------------------------------------------------------------

The TSX announced today, that it has extended the review of LMS’ listing for another 60 days.

One can speculate that the recently announced deal with McKesson for the rights to LMS’ Clinical Information System (CIS) was a step in the right direction. A key question that remains to be answered is what if any new equity capital will be required by LMS, as well as what does the business and growth prospects look like going forward.

Stay tuned…

For the full release, please click here

McKesson Solution “Builds Strength” with Acquisition of LMS Software

LMS Medical Systems (LMZ - TSX)

Shares outstanding: 25.8m

Fully Diluted: 30.7 million

-----------------------------------------------

Today, McKesson formally announced its agreement with LMS Medical Systems to purchase its Clinical Information System (CIS). In its news release McKesson acknowledges that its Horizon Clinicals ® has been strengthened by the acquisition of LMS’ OB surveillance and archival solution. Currently being marketed by McKesson as Horizon Perinatal Care™ it is already used by more than 60 customers in the United States.

The company states that Horizon Perinatal Care is the first and only OB/perinatal information solution designed to support continuity of care between labor and delivery and other areas in the hospital.

To read the full release, please click here

AMA Lands Another Middle East Airline Customer

AeroMechanical Services Ltd. (TSX:V-AMA)

Basic Shares: 82.5 million

Fully Diluted: 88 million

******************************************

Much of the world is in the grips of a miserable recessionary flu.

But AeroMechanical found yet another customer in a region that isn't bedridden.

The Middle East.

The latest of three recently announced contracts in that region is to a Middle East carrier that has a mixed fleet of Boeing 767, 737 an Airbus A320 aircraft.

The contract could be worth up to $2.62 million over the length of the five-year deal.

The unidentified airline was interested in AMA's ability to quickly pinpoint where its aircraft are burning excessive fuel. In addition, the airline will benefit from the other capabilities of AMA's technology to better handle maintenance, scheduling and to communicate with its pilots where ever they are flying in the world.

On the flip side, employing AMA's technology also allows the airline to significantly cut its carbon footprint, given that a large passenger jet emits between 1,300-2,000 tonnes of CO2 per aircraft every year.

AMA's technology can help an airline reduce an aircraft's fuel burn by up to 5%. But assuming a more conservative 3% cutback, the airline could cut each of its aircraft's carbon footprint by 39 to 60 tonnes every year.

Using the same calculations, an airline with 100 aircraft could cut its carbon emissions by up to 6,000 tonnes, not to mention the millions of dollars in savings to its fuel bill and the avoidance of the new carbon tax announced by the EU last year.

AMA has made major strides with its new fuel program in helping airlines get a handle one of their largest expenditures.

As mentioned earlier, this is the third of three airline relatively recent contracts in the region.

Last November, AMA announced it signed a contract with a leading Canadian electronics provider which was modernizing a Middle Eastern military organization's fleet of Lockheed Martin C-130H Hercules aircraft.

Before the latter contract, a different Middle East airline installed AMA's technology.

To read the full news release on this latest business development, please click here.

LMS Medical Announces Much Anticipated McKesson Deal

LMS Medical Systems (LMZ - TSX)
Shares outstanding: 25.8m
Fully Diluted: 30.7 million
-----------------------------------------------

Investors rewarded LMS’ McKesson deal announcement on Monday with a nice 114% jump in its share price. According to the release, LMS Medical sold its Clinical Information System (CIS) to McKesson for an undisclosed amount. However, the release did outline some of the terms of the sale, including LMS’ ability to continue to sell the CIS software outside of McKesson’s customer base and the fact that LMS will continue to provide maintenance & support services to McKesson’s CIS clients. The maintenance & service support will equate to up to $3 million per year at least until the end of fiscal 2010 (March 31, 2010).

Not covered in the arrangement were three Risk Management Tools (Shoulder, Calm, Patterns), which suggests that LMS still has considerable business that it can continue to develop on its own or potentially in partnership with other companies.

There are still a few unknowns out there that would completely assure shareholders of its future such as management’s perspective on future growth opportunities and the business going forward. Investors have been living with a great degree of uncertainty over the past six months as LMS’ financial position was shaky at best. We expect this development will be seen as a positive development by the TSX Exchange, which had the company under a watch with its continued listing on the senior board very much up in the air. However this announcement is a great first step to shoring up LMS’ future.

We’re looking forward to seeing what happens in the coming weeks.

To read the full release, please click here.

Med BioGene Featured in Top Industry Publication

MED BIOGENE INC. (MBI:TSX-V)

Basic shares: 40 million

Fully diluted: 58 million

------------------------------------------------------------------------

On March 24, 2008 GenomeWeb.com featured Med BioGene in an article titled, “Med BioGene Will Launch LungExpress Dx in H2, Establish US Office, CEO Says.”
Highlights from the article include:

- According to CEO Erinn Broshko, Med BioGene is on track to launch its LungExpress assay in the second half of this year and will likely open a US office to support the test, which will initially be offered in a Clinical Laboratory Improvement Amendment (CLIA) -compliant partner lab.

- …LungExpress Dx has the potential to increase the five-year survival rate by up to 33 percent while decreasing health care costs significantly.

- The main reason for the expected cost savings is a decrease in treatment failure and terminal care costs associated with cancer recurrence, which in the United States can range between $150,000 to $500,000 per patient, the firm claims.

- In terms of other gene-expression signatures for Non-small Cell Lunch Cancer (CSLC), MBI is the only group with a signature predictive of adjuvant chemotherapy benefit and prognostic for survival.

To read the full article, please click here

About GenomeWeb.com

GenomeWeb (http://www.genomeweb.com/ ) is an independent, privately-held online and print publisher based in New York. Since 1997, GenomeWeb has served the global community of scientists, technology professionals, and executives who use and develop the latest advanced tools in molecular biology research.

GenomeWeb's editorial mission is to serve readers with exclusive, in-depth coverage of the technology, institutions, and scientists that make up the worldwide research enterprise of molecular biology. We operate the largest online news organization focused on advanced research tools in genomics, proteomics, and bioinformatics. Our expert editors report and write with precision and clarity.

GenomeWeb users can be found in major scientific organizations around the world, including biopharmaceutical companies, important research universities, biomedical institutes, and government laboratories. Our advertisers include leading suppliers of research tools, analytical instruments, and information technology.

LMS Appoints Risk Management Veteran to CEO/CFO Position

LMS Medical Systems (LMZ - TSX)
Shares outstanding: 25.8m
Fully Diluted: 30.7 million
--------------------------------------------

Today, LMS announced that Yves Grou has been replaced by William Horn as Interim CEO/CFO. This news comes to us as shareholders anxiously await news of a “deal”, which ideally will give LMS Medical the finances and support it needs to continue to operate and thrive.

Below is Mr. Horn’s background as released when he was appointed to LMS’ Board of Directors.

William Horn is the Chief Operating Officer of First Angel Capital LLC, an investment boutique and private investment fund. From 2001 to 2004 Mr Horn was at State Street Corporation, Boston , MA where he was Vice President, Risk Management & Compliance.

Mr. Horn spent the eight years prior involved with Fidelity Capital Markets and Fidelity Management and Research Company in roles that involved Counterpart research, global Risk Management, and fixed income trading.

For the full release, please click here.